NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
30 hedge funds and large institutions have $921K invested in NexImmune, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
0.22% less ownership
Funds ownership: 17.08% → 16.85% (-0.22%)
6% less funds holding
Funds holding: 32 → 30 (-2)
27% less capital invested
Capital invested by funds: $1.26M → $921K (-$334K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.06K |
| 3 |
Renaissance Technologies
New York
|
+$2.21K |
| 4 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$341 |
| 5 |
Morgan Stanley
New York
|
+$112 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$22.9K |
| 2 |
Jane Street
New York
|
-$12.7K |
| 3 |
HF
HRT Financial
New York
|
-$11K |
| 4 |
DC
Davenport & Co
Richmond,
Virginia
|
-$7.33K |
| 5 |
Millennium Management
New York
|
-$3.21K |
NEXI Hedge Fund Activity: Q3 2023 in Review
30 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q3 2023, worth a combined $921K — down 27% from $1.26M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NEXI and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was Geode Capital Management, adding an estimated $11.5K. The largest seller was Envestnet Asset Management, exiting entirely with an estimated $22.9K sold.
- 30 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q3 2023, down from 32 in Q2 2023.
- Funds reported $921K of NexImmune, Inc. Common Stock stock for Q3 2023, down 27% quarter-over-quarter.
- 2 funds opened new NexImmune, Inc. Common Stock positions in Q3 2023 and 4 closed out, a net change of -2 holders.
- The largest NexImmune, Inc. Common Stock buyer in Q3 2023 was Geode Capital Management, an estimated $11.5K added.
- The largest NexImmune, Inc. Common Stock seller in Q3 2023 was Envestnet Asset Management, an estimated $22.9K sold.
Based on aggregated 13F filings for Q3 2023.